Social Links

Follow on Facebook Follow on Twitter Follow on G+Follow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

DNRS Roof Banner

 

DNRS Interactive DVD Series & Seminars

Intestinal Dysbiosis and the Causes of Disease - References

 

 

 

 

l. Mentioned in Brown JP. Role of gut bacterial flora in nutrition and health: a review of recent advances in bacteriological techniques, metabolism and factors affecting flora composition. CRC Rev Food Sci Nutr 1977 8:229-336.

 

2. Haenel H, Bendig J. Intestinal flora in health and disease. Prog Food Nutr Sci 1975, 1:21-64.

 

3. Berghouse L, Hon S, Hill M, et al. Comparison between the bacterial and oligosaccharide content of ileostomy effluent in subjects taking diets rich in refined or unrefined carbohydrate. Gut 1984; 25:1071-1077.

 

4. Galland L. Effects of intestinal microbes on systemic immunity. Post Viral Fatigue Syndrome, Mowbray P, Jenkins R eds. John Wiley & Sons, London, 1991; 405430.

 

5. Newmark HL, Lupton JR. Determinants and consequences of colonic luminal pH: implications for colon cancer. Nutr and Cancer 1990; 14:161-173.

 

6. Goldin BR. The metabolism of the intestinal microflora and its relationship to di- etary tat, colon and breast cancer. Dietary Fat and Cancer New York, Alan R. Liss 1986 655-685.

 

7. Malhotra SL. Fecal urobilinogen levels and pH of stools. J Royal Soc Med 1982; 75:710.

 

8. Chung K-T, Fulk GE, Slein MW. Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J Natl Can Inst 1975, 54:1073-1078.

 

9. Hill MJ, Melviulle DM, LennardÇJones JE, Neale K, Ritchie JK. Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987; 2:185-186.

 

10. Bennet JD. Ulcerative colitis: the result of an altered bacterial metabolism of bile acids or cholesterol. Med Hypoth 1986, 20:125-132.

 

11. Effects of short-chain fatty acids on a human colon carcinoma cell line. Nutr Rev (United States) 1988; 46(1):11-12.

 

12. Breuer Rl. Rectal irrigation with short-chain fatty acids. Dig Dis Sci 1991; 2:185-187.

 

13. Kistler LA, Gianella RA. Relationship of intestinal bacteria to malabsorption. Pract Gastroenterol 1980; 4:24-44.

 

14. Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetra- cycline. Gastroenterol 1991; 100:513-519.

 

15. du Moulin GC, Hedley-White J. The stomach as a bacterial reservoir: clinical significance. IM: Internal Medicine for the Specialist 1982; 3:47-55.

 

16. Serrander R, Magnusson K-E, Kihlstrom E, Sundqvist T. Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand J Inf Dis 1986, 18:409-412.

 

17. Bode JC, Rust S, Bode C. The effect of cimetidine treatment on ethanol formation in the human stomach. 9and J Gastroenterol 1984; 19:853-856.

 

18. Hunnisett A, Howard J, Davies S. Gut fermentation (or the auto-brewery) syn- drome: a new clinical test with initial observations and discussion of clinical and biochemical implications. J Nutr Med 1990; 1:33-38.

 

19. Sudduth WH. The role of bacteria and enterotoxemia in physical addiction to alcohol. Microecology and Therapy 1989; 18: 77-81.

 

20. Thurn JR, Pierpont GL, Ludvigsen CW, Eckfeldt JH. D-lactate encephalopathy. Am J Med 1985; 79:717-721.

 

21. Ionescu G, Kiehl R, Ona L, Schuler R. Abnormal fecal microflora and malabsorption phenomena in atopic eczema patients. J Adv Med 1990; 3:71-89.

 

22. Ionescu G, Kiehl R, Wichmann-Kunz F, Leimbeck R. Immunobiological significance of fungal and bacterial infections in atopic eczema. J Adv Med 1990; 3:47-58.

 

23. Ionescu G, Kiehl R, Wichmann-Kunz F, Williams C, et al. Oral citrus seed extract in atopic eezema: In vitro and in vivo studies on intestinaˆ microflora. J Orthomoˆ Med 1990, 5:155-161.

 

24. Alun Jones V, Shorthouse M, McLaughlin P, et al. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1980 2:1115-1117.

 

25. Bayhss CE, Bradley HK, Alun Jones V, Hunter JO. Some aspects of colonic microblal actlvlty in irritable bowel syndrome associated with food intolerance. Annalidell Istituto Superiore di Sanita 1986, 22:959-964.

 

26. Hunter JO, Alun Jones V. Studies on the pathogenesis of irritable bowel svndrome produced by food intolerance. Read NW, ed, The Irritable Bowel Syndro;ne, New York, Grune and Stratton, 1985; 185-190.

 

27. Alun Jones V, Wilson AJ, Hunter JO, Robinson RE. The aetiological role of antibilotgi8c4pr5o/phYlalxli)ssw2ith hysterectomy in irritable bowel syndrome J Ob and Gyn

 

28. Shorter RG, Huizenga KA, Spencer BJ. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Digest Dis 1972;

 

29. Beeken WL. Remedial defects in Crohn disease. Arch Int Med 1975, 135:686-690.

 

30. Hollander D, Vadheim C, Brettholz E, et al. Increased intestinal permeabilitv in patients with Crohn's disease and their relatives. Ann Int Med 1986, 105 883-885

 

31. Giaffer MH, Holsworth CD. Effects of an elemental diet on the the faecal ‡lora of patients with Crohn's disease. 9and J Gastroenterol 1989; 24(suppl): S148.

 

32. Bennett JD Use of a-tocopherylquinone in the treatment of ulcerative colitis. Gut

 

33. Gottschall E. Food and the Gut Reaction. Kirkton, Ontario, The Kirkton Press 1986.

 

34. McCann M. J Allergy Clin Immunol, 1993 (In Press).

 

35. Inman RD. Reactive arthritis, Reiter's syndrome, and enteric pathogens. Infections in The Rheumatic Diseases. In: Espinoza L, Goldenberg D, Arnett F, Alarcon G eds. Orlando, FL Grune & Stratton; 1988: 273-280.

 

36. Gransfors KF Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989 320:216-221.

 

37. Gransfors K, Jalkanen S, Lindberg AA, et al. Salmonella iipopolysaccaride in synovlal cells from patients with reactive arthritis. Lancet 1990, 1: 685-688.

 

38. Fox A. Role of bacterial debris in inflammatory diseases of the joint and eye APMIS 1990; 98:957-968.

 

39. Phillips PE. How do bacteria cause chronic arthritis? J Rheumatol 1989; 16: 1017-1019.

 

40. Rooney PJ, Jenkins RT, Buchanan WW. A short review of the relationship be- tween intestinal permeability and inflammatory joint disease. Clin and Exp Rheu- amatol 1990; 8:75-83.

 

41. Ebringer A, Cox N, Abuljadayel I, et al. Klebsiella antibodies in ankylosing spondylitis and proteus antibodies in rheumatoid arthritis. Brit J of Rheumatol 1988 27(suppl II): 72-85.

 

42. McGuignan LE, Prendergast JK, Geczy AF, et al. Significance of nonpathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis 1986; 45:577-571.

 

43. Husby G, Tsuchiya N, Schwinmmbeck PL, et al. Cross-reactive epitope with Klebslella pneumoniae nitrogenase in articular tissue of HLA-B27 + patients with ankylosing spondylitis. Arth Rheum 1989, 32:437-445.

 

44. Malhotra SL. Faecal urobilinogen levels and pH of stools in population groups with different incidence of cancer of the colon, and their possible role in its aetiology. J Royal Soc Med 1982, 75:709-714

 

45. Walker ARP, Walker BF, Walker AJ. Faecal pH, dietary fiber intake, and proneness to colon cancer in four South Afncan populations. Brit J Canc 1986; 53:489-495.

 

46. Rowland IR. Factors affecting metabolic activity of the intestinal microflora. Drug Metabol Rev 1988; 19:243-261.

 

47. Rowland IR, Mallett AK. Dietary fiber and the gut microflora -their effects on toxicity. In: Chambers PL, Gehring P, Sakai F, eds, Amsterdam. New Concepts and Developments in Toxicology, 1986: 125-138.

 

48. Freudenheim J, Graham S, Horvath P. Risks associated with source of flber and fiber components in cancer of the colon and rectum. Canc Res 1990; 50:3295-3300.

 

49. DeCosse JJ, Miller HH, Lesser ML. Effect of wheat fiber and vltamins C and E on rectal polyps in patients with familial adenomatous polyps. J Natl Canc Inst 1989; 81:1290-1297.

 

50. Alberts D, Einspahr J, Rees-McGee S. Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. J Natl Canc Inst 1990; 82:1280-1285.

 

51. Heitman DW, Cameron IL. Reduction of colon cancer risk by dietary cellulose supplementation. J Natl Canc Inst 1990; 82:1154-1155.

 

52. Mitsuoka T, Hidaka H, Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Die Nahrung 1987; 31:427436.

 

53. Guggenbichler JP, Allerberger F, Hofstotter H, Dierich MP. Oral therapy for acute diarrhea. N Eng J Med 1991; 324:1672-1673.

 

54. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhea in six patients. Lancet 1989; 1:1156-1160.

 

55. Ayebo AD, Angelo IA and Shahani KM. Effect of ingesting acidophilus milk upon fecal flora and enzyme activity in humans. Milchwissenschaft 1980; 35:730-733.

 

56. Gorbach SL. Lactic acid bacteria and human health. Ann Med 1990; 22:37-41.

 

57. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobaclllus GG yogurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22:57-59.

 

58. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travelers' diarrhoea by Lactobacillus GG. Ann Med 1990; 22:53-56.

 

59. Mitsuoka T. Bifidobacteria and their role in human health. J Ind Microbiol 1990; 6:263-268.

 

60. Yabbara KF, Juffali F, Matossian RM. Bacillus laterosporus endopthalmitis. Arch Ophthalmol 1977; 95:2187-2189.

 

61. Okube M, Inoue K, Umetani N, et al. Lupus nephropathy in New Zealand Fl hybrid mice treated by ( - )15-deoxyspergualin. Kidney Intl 1988; 34:467-473.

 

62. Umezawa K, Takeuchi T. Spergualin: a new antitumor antibiotic. Biomed Pharmacotherapy 1987; 41:227-232.

 

63. Shoji J, Sakazaki R, Wakisaka Y, et al. Isolation of a new antibiotic, lat- erosporamine. Studies on antibiotics from the genus Bacillus Xlll. J Antiblotlcs (Tokyo) 1976; 29:390-393.

 

64. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospectlve study. Gastroenterol 1989; 96:981-988.

 

65. Castex F, Corthier G, Jouvert S, et al. Prevention of Clostridium difflcile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study. J Gen Microbiol 1990; 136:1085-1089.

 

66. Buts J-P, Bernasconi P, Vaerman J-P, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins sn small mtestme of rats treated withSaccharomyces boulardii. Dig Dis 9i 1990: 35:251-256.

 

67. Klayman DL. Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985, 228.1049-1055.

 

68. Levander OA, Ager A, Morris VC, May RG. Qinghaosu, dietary vitamin E, selenium and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii. Am J Clin Nutr 1989; 50:346-352.

 


 

 

Related Articles: